Laboratory Of America Holdings' Sonora Quest Appoints Jennifer Erickson as New CEO-Elect
- Jennifer Erickson is appointed as CEO-Elect of Sonora Quest Laboratories, succeeding David Dexter after 26 years of leadership.
- Under Dexter, Sonora Quest became Arizona's leading clinical lab, processing over 100 million tests annually and innovating services.
- Erickson aims to continue growth and innovation, focusing on advancing diagnostics and strengthening healthcare partnerships post-pandemic.
Sonora Quest Laboratories Welcomes New Leadership Amidst Legacy of Innovation
Sonora Quest Laboratories, a subsidiary of Laboratory Sciences of Arizona (LSA), appoints Jennifer Erickson as the new Chief Executive Officer-Elect, succeeding the esteemed David Dexter, who has dedicated over 26 years to leading the organization. Dexter plans to retire on March 31, 2026, leaving behind a robust legacy that has established Sonora Quest as the foremost clinical laboratory testing provider in Arizona. Under his leadership, the company has processed over 100 million diagnostic tests annually and spearheaded numerous pivotal initiatives, including the introduction of the My Lab ReQuest™ platform in 2015, which allows direct-access testing, and the expansion of COVID-19 testing through Operation Catapult in 2020. These efforts, alongside strategic partnerships with organizations like the American Cancer Society, have solidified Sonora Quest’s position as a leader in the healthcare sector.
Jennifer Erickson's appointment marks a significant transition for Sonora Quest, as she brings over 20 years of expertise in healthcare and consumer services. Having served as the Chief Financial Officer of Sonora Quest from 1999 to 2004, Erickson is well-acquainted with the company's culture and operational framework. Her recent experience as CFO and COO of Clin-Path Associates/Pathology Specialists of Arizona further equips her with the necessary skills to enhance patient-centered diagnostics. Dexter, who has played a crucial role in mentoring Erickson throughout her career, expresses confidence in her ability to uphold the company's values of collaboration and accountability as she steps into her new role.
As the new CEO-Elect, Erickson aims to continue the trajectory of growth and innovation that has characterized Sonora Quest Laboratories under Dexter’s stewardship. Her focus will be on advancing diagnostic services and strengthening partnerships within the healthcare community, ensuring that the organization remains responsive to the evolving needs of patients and healthcare providers alike. This commitment to innovation and collaboration is crucial for navigating the complexities of modern healthcare, especially as the industry continues to adapt post-pandemic.
In addition to the leadership change, the transition underscores the importance of mentorship and continuity within the company. Dexter’s long tenure has not only shaped the organization’s operational successes but also fostered a culture of nurturing talent from within. As Erickson prepares to take the helm, she carries forward a rich legacy that emphasizes both innovation in laboratory services and a steadfast commitment to community health. The leadership transition at Sonora Quest Laboratories signifies a pivotal moment, promising to enhance the company’s role in delivering vital diagnostic services to the Arizona community and beyond.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

